CHF19.75
1.80% yesterday
SIX Swiss Exchange, Jun 27, 05:31 pm CET
ISIN
CH0461929603
Symbol
XLS
Sector
Industry

Xlife Sciences Stock price

CHF19.75
-0.20 1.00% 1M
-5.05 20.36% 6M
-5.65 22.24% YTD
-9.95 33.50% 1Y
-10.65 35.03% 3Y
-32.25 62.02% 5Y
-32.25 62.02% 10Y
-32.25 62.02% 20Y
SIX Swiss Exchange, Closing price Fri, Jun 27 2025
+0.35 1.80%
ISIN
CH0461929603
Symbol
XLS
Sector
Industry

Key metrics

Basic
Market capitalization
CHF111.4m
Enterprise Value
CHF170.6m
Net debt
CHF59.2m
Cash
CHF100.0k
Shares outstanding
5.7m
Valuation (TTM | estimate)
P/E
4.23 | negative
P/S
134.21 | 51.93
EV/Sales
205.55 | 79.54
EV/FCF
negative
P/B
0.37
Financial Health
Equity Ratio
56.49%
Return on Equity
11.23%
ROCE
-3.64%
ROIC
-4.32%
Debt/Equity
0.19
Financials (TTM | estimate)
Revenue
CHF830.0k | CHF2.1m
EBITDA
CHF-3.3m | CHF-6.9m
EBIT
CHF-19.3m
Net Income
CHF34.3m | CHF-3.7m
Free Cash Flow
CHF-430.0k
Growth (TTM | estimate)
Revenue
-16.16% | 158.43%
EBITDA
23.00% | -108.36%
EBIT
4.66%
Net Income
130.38% | -110.85%
Free Cash Flow
-430.77%
Margin (TTM | estimate)
Gross
65.82%
EBITDA
-393.42% | -322.49%
EBIT
-2,317.21%
Net
4,105.50% | -173.52%
Free Cash Flow
-51.93%
More
EPS
CHF4.67
FCF per Share
CHF-0.08
Short interest
-
Employees
17.00
Rev per Employee
CHF50.00k
Show more

Is Xlife Sciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Xlife Sciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Xlife Sciences forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Xlife Sciences forecast:

Buy
80%
Hold
20%

Financial data from Xlife Sciences

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.83 0.83
16% 16%
100%
- Direct Costs 0.29 0.29
46% 46%
35%
0.55 0.55
22% 22%
66%
- Selling and Administrative Expenses 4.21 4.21
8% 8%
507%
- Research and Development Expense - -
-
-
-3.28 -3.28
23% 23%
-395%
- Depreciation and Amortization 16 16
0% 0%
1,935%
EBIT (Operating Income) EBIT -19 -19
5% 5%
-2,331%
Net Profit 34 34
130% 130%
4,130%

In millions CHF.

Don't miss a Thing! We will send you all news about Xlife Sciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Switzerland.

Head office Switzerland
CEO Oliver Baumann
Employees 17
Website www.xlifesciences.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today